As a limitation of our study, the relatively small sample size may have underpowered some differences; e.g., although 4/6 IIMs-ILD patients with anti-MDA5 positivity developed PF-ILD, the data were not statistically significant. This evidence concerns the gene IFIH1 and interstitial lung disease.